Evidence map›Paper›PMID 40926665›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Bullvalene-Containing Molecular Glasses.

Yuzhen Wen, Christopher Hogg, Mariia Kuznetsova, Aisha N Bismillah, Stephen J Cowling, Paul R McGonigal

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Bullvalene-Containing Molecular Glasses.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuzhen WenDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
Christopher HoggDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
Mariia KuznetsovaDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
Aisha N BismillahDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
Stephen J CowlingDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
Paul R McGonigalDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK.ORCID https://orcid.org/0000-0002-8538-7579

Funding

China Scholarship CouncilEPSRC EP/V040049/2EPSRC EP/Z00036X/1Wild Fund
6 · The paper itself

Abstract

Organic molecular glasses are attractive matrices to disperse active ingredients in pharmaceuticals or electronic devices. Typically, they i) have lower glass transition temperatures than inorganic or polymeric glasses, making them easier to process, and ii) are less prone to phase segregation from other organic active materials. However, there is a dearth of functional groups that are known to induce glass formation in preference to crystallization. We have investigated the relationship between the shapeshifting isomerism of heterodisubstituted bullvalenes (BVs) and their properties as amorphous molecular glasses. Substituting a constitutionally dynamic BV unit in place of the 1,4-phenylene motif in the molecular structures of two well-known liquid crystal mesogens, 4-cyano-4'-pentylbiphenyl and 4-cyano-4'-butylbiphenyl, produces materials that readily form glasses. The properties of the two glasses are compared to analogous glasses with fixed constitutions. Using differential scanning calorimetry (DSC) and polarized optical microscopy (POM), we show that, unlike the fixed-structure glasses, the BV-containing molecular glasses fracture at low temperatures, which is indicative of them having larger thermal expansion coefficients. This article highlights the capability of shapeshifting building blocks to induce glass formation and to alter the physical properties of the resulting molecular materials, producing macroscopic effects that are observable by eye.

Indexed as

AmorphousBullvaleneFluxionalityGlassesRearrangement

Identifiers

PMID40926665
PMCPMC12535393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.